Learn

Saturday, 21 November

FMGE · blueprint and recall

FMGE Insulin and oral antidiabetics

Candidates recalled insulin and oral antidiabetics from 10 of the 19 FMGE sessions in this collection, including 8 of the 11 well-covered ones. It first appears in FMGE Jun 2009 and last in FMGE Jul 2025. 8 of its 10 recalled concepts came as one-liners.

Concepts in recalled topics
10
unofficial
Sessions seen in
10
Well-covered sessions
8
with this topic recorded
Image-linked concepts
0

Recurrence in this collection

Each recalled session counts once for this topic, even if it contains several related concepts.

Seen in 10 of the 19 sessions with recall; 8 of the 11 well-covered sessions.

First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.

Question styles and image links

Question styles in the recall

one-liner
8 concepts · 80.0%
vignette
2 concepts · 20.0%

Within this topic

Finer labels from the unofficial recall, grouped under Lumi's outline topic.

Subtopics represented

  • Diabetes insipidus
  • Incretin mimetics
  • Antidiabetic adverse effects
  • Insulin and oral antidiabetics
  • Antidiabetics in cardio-renal disease
  • Oral antidiabetics

Image types recorded

No concepts recorded in this category.

Image-type percentages use all 10 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.

Related topics in this chapter

  • Endocrine

    Thyroid drugs

    Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Jun 2011. Last seen: FMGE Jun 2022.

    Styles: one-liner (3) · vignette (1).

  • Endocrine

    Sex hormones and contraceptives

    Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Jul 2025.

    Styles: one-liner (2).

  • Endocrine

    Corticosteroids

    Seen in 4 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jun 2019.

    Styles: one-liner (3).

  • Endocrine

    Drugs for osteoporosis

    Seen in 1 of the 19 sessions with recall; 1 of the 11 well-covered sessions.

    First seen: FMGE Jan 2025. Last seen: FMGE Jan 2025.

    Styles: one-liner (1).

All of Endocrine, including unseen topics →